about
Ischemic heart disease in women: a focus on risk factorsHormonal contraceptives: pharmacology tailored to women's healthCoronary artery disease in Bangladesh: a reviewGreater Beta-Adrenergic Receptor Mediated Vasodilation in Women Using Oral ContraceptivesMetabolic effects of contraceptive steroidsEffects of oral contraceptives on sympathetic nerve activity during orthostatic stress in young, healthy women.Reproductive hormone exposure timing and ischemic heart disease: Complicated answers to a simple question.Oral contraceptive use among women in the military and the general U.S. populationA combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation.The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study.The impact of estradiol and 1,25(OH)2D3 on metabolic syndrome in middle-aged Taiwanese males.Nonsurgical outpatient therapies for the management of female stress urinary incontinence: long-term effectiveness and durabilityPast oral contraceptive use and self-reported high blood pressure in postmenopausal women.Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease.Reproductive history and mortality from cardiovascular disease among women textile workers in Shanghai, China.Oral contraceptive use, iron stores and vascular endothelial function in healthy womenOral contraceptives modify DNA methylation and monocyte-derived macrophage function.Adverse pregnancy outcomes and cardiovascular risk factor managementCardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunctionAssociations between oral contraceptive use and risks of hypertension and prehypertension in a cross-sectional study of Korean womenAssociation of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States.Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association.Contraception in patients with heart failureCardiovascular disease is preventable among women.Estrogen-free oral hormonal contraception: benefits of the progestin-only pill.Estrogen and thrombosis: controversies and common sense.Contraception and headache.Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study.Identifiable hypertension: a new spectrum.Oral contraceptives and nicotine synergistically exacerbate cerebral ischemic injury in the female brain.Bridging the gender gap in atrial fibrillation.Association between duration of oral contraceptive use and risk of hypertension: A meta-analysis.Dyslipidemia and cardiovascular disease in women.RAS and sex differences in diabetic nephropathy.Molecular screening of Chinese medicinal plants for progestogenic and anti-progestogenic activity.Cardiovascular disease incidence among females in South Carolina by type of oral contraceptives, 2000-2013: a retrospective cohort studyTailoring cardiovascular risk assessment and prevention for women: One size does not fit all.Altered cardiovascular adaptability in depressed patients without heart disease.Comprehensive review of cardiovascular toxicity of drugs and related agents.Comprehensive primary prevention of cardiovascular disease in women.
P2860
Q22251459-1134AA8F-C38D-4A44-8516-92E915029030Q26745814-A37F08B3-4DE4-46C3-A97F-CFDA8F237DB2Q27024688-B2414E6C-1DE2-40F9-8831-1E47A689B55BQ27307777-20787192-2A8F-4457-AE21-6BF305918D0CQ28236638-119DF065-FAE1-4E0D-B8F7-94D3D0143D83Q33589548-9FC36F9C-A0EE-4FAD-91F0-BA8C52694FA8Q33796458-CF5A9845-3C0F-4198-936D-F28835614625Q34132130-C2FA199A-AC90-436F-8394-3C56EBA0CB72Q34145361-BBB50FE2-F7A0-491C-B595-F41249279FD7Q34476667-79006BF3-D064-4C4C-A186-95F2B21B9B3CQ34653701-202F32F5-7DA5-493E-AFBA-B359D9B2D833Q35070906-4FDEB3A6-136C-42B3-9F70-B0938A22C467Q35083066-FA2537AD-7CC6-4B3E-9764-3D88E5D115F7Q35282590-467B6A4E-C22E-4618-A72D-D9E74F9D43ADQ35605247-0CC3085B-BD28-4DEC-94A7-D9E791B9D2E9Q35774926-E5A4151B-BA0D-4D11-BBAC-195C7A4AD267Q35818370-468700D7-AF9C-4C1F-A948-DC8B96BC91D1Q35893804-C28CCE36-9CDB-4703-9732-311AF28CEFCDQ37339431-90676037-B532-4106-967C-EED4154FB227Q37368564-E71A1C01-79B0-49D5-B541-D0A117210DD4Q37463944-47509056-9F21-4054-B8C7-D680EAA215FAQ37499363-B2D5F29A-3E47-464D-AE29-17221C3CDBE0Q37598754-BCC36457-161B-44A6-8E0C-2B4692F144CEQ37688153-5865D145-EB29-4D63-AC92-4A6E1BA67C99Q37809855-C05987DB-BBBC-4101-9514-B107CF03104EQ37874154-E1C2DC4F-321B-4C71-9FAD-22CC7DF4254CQ38083769-D6B240C3-3BA7-4CAF-80D1-CAD70D4A7CE2Q38110189-39761E07-3B92-4F55-A8F1-A19072A67768Q38148619-FEB067D1-8087-4D96-92A5-5B2316A5E225Q38169998-BA2181D2-A02F-440E-8D8D-9D4C6E9FD99AQ38317687-B7A66274-294E-4953-A71B-F5B29E1CEEEBQ38370311-33866C9C-0609-42FF-8974-E54B3D6E000BQ38508952-05AFBDEF-BCDE-4C3E-8FA3-CE0945744717Q38768074-794ED83A-7706-4782-8D21-E14BB23D4201Q38993290-70ECC89F-287A-4A00-9A2C-0C0FA95B46A5Q39611791-1123A4F8-4FF0-4B39-9D71-A865B224D0C9Q41856851-51816AD8-EA66-4399-AE3C-8D16CBC13B69Q43553642-73C0EDEA-D439-4409-B7D5-D02C85181DD1Q47556269-B2F8D8E7-E5C4-4669-BDC8-859DD7C5B6FDQ48166851-C0451318-FE5C-424D-B645-BF18E71BE12C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contraceptive hormone use and cardiovascular disease
@en
Contraceptive hormone use and cardiovascular disease.
@nl
type
label
Contraceptive hormone use and cardiovascular disease
@en
Contraceptive hormone use and cardiovascular disease.
@nl
prefLabel
Contraceptive hormone use and cardiovascular disease
@en
Contraceptive hormone use and cardiovascular disease.
@nl
P2860
P1476
Contraceptive hormone use and cardiovascular disease
@en
P2093
Chrisandra L Shufelt
P2860
P304
P356
10.1016/J.JACC.2008.09.042
P407
P577
2009-01-01T00:00:00Z